Procurement Summary
Country: Macedonia
Summary: Medicines According to Technical Specification
Deadline: 10 Jul 2026
Posting Date: 11 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143068040
Document Ref. No.: 10390/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33000000 - Medical equipments, pharmaceuticals and personal care products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
In tender documentation1. R03DA05 - Aminophylline 250 mg/ 10 ml, 2. J01MA02 - Ciprofloxacin 100 mg/10 ml, 3. J01GB03- Gentamicin 120 mg/ 2ml; 120mg/1.5ml, 4. J01FF01 - Clindamycin 300 mg/2 ml, 5. J01FF01 - Clindamycin 600 mg/4 ml, 6. N02AA01 - Morphine 20 mg/1 ml, 7. M01AE03 - Ketoprofen 100 mg/2 ml, 8. N02AX02 - Tramadol 100 mg/2 ml, 9. A02BA02 - Famotidine 20mg/2ml, 10. J01AA12 - Tygecycline 50 mg, 11. J01DD02 - Ceftazidime 1000 mg, 12. J01DD04 - Ceftriaxone 2000 mg (2gr), 13. N05BA01 - Diazepam 5 mg/1 ml; 10mg/2ml, 14. B03BA01 - Cyanocobalamin 500 mcg/1 ml, 15. A05BA06 - l-ornithine-l-aspartate 5 g/10 ml, 16. A02BC02 - Pantoprazole 40 mg, 17. B05AA01 - Albumin 20%, 18. A11HA02 - Pyridoxine 50 mg, 19. B01AB01 - Heparin 25 000 IE/5 ml, 20. A03FA01 - Metoclopramide 10 mg/2 ml, 21. H02AB02 - Dexamethasone 4 mg/1 ml, 22. A11GA01 - Ascorbic acid 500 mg/5 ml, 23. J01GB06 - Amikacin 500 mg/2 ml, 24. J01XA01 - Vancomycin 1000 mg (1gr), 25. B01AB05 - Enoxaparin (originator) 2000 anti-Xa IE/0.2ml, 26. B01AB05 - Enoxaparin (originator) 4000 anti-Xa IE/0.4ml, 27. B01AB05 - Enoxaparine (bioslichen) 2000 anti-Xa IE/0.2ml, 28. B01AB05 - Enoxaparine (bioslichen) 4000 anti-Xa IE/0.4ml, 29. C01CA04 - Dopamine 40 mg/1 ml, 30. B05BA03 - Glucose 35%, 31. C01BD01 - Amiodarone 150 mg/3 ml, 32. C01CA24 - Adrenaline 1mg/1ml, 33. C03CA01 - Furosemide 20 mg/2 ml, 34. C09AA02 - Enalapril 1, 25 mg/1 ml, 35. A03BB01 - Hyoscine butylbromide 20mg/1ml, 36. H01CB02 - Octreotide 0, 1 mg/1 ml, 37. B02AA02 - Tranexamic acid 500 mg/5 ml, 38. H02AB...
CPV Descriptions: Medical equipment, pharmaceuticals and personal care products
Documents
Tender Notice
Document_1.docx
Document_2.docx
Document_3.xls
Document_4.pdf